{"recordsFiltered":48703,"recordsTotal":48703,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=title&start=35100","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=title&start=34500","results":[{"registry_id":"NCT05643638","publication_url":"https://clinicaltrials.gov/study/NCT05643638","title":"A Multicenter, Randomized, Double-blind, Placebo-Controlled Phase II Study to Investigate the Efficacy and Safety of CYP-001 in Combination With Corticosteroids vs Corticosteroids Alone for the Treatment of High-Risk Acute Graft Versus Host Disease","has_exemption":false,"start_date":"2024-03-04","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Cynata Therapeutics Limited","sponsor_slug":"cynata-therapeutics-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05689021","publication_url":"https://clinicaltrials.gov/study/NCT05689021","title":"Phase 2 Study of CJNJ-67652000 (Niraparib/Abiraterone Acetate Fixed-Dose Combination) and Prednisone for Metastatic Castration-Resistant Prostate Cancer Associated With SPOP Mutation With or Without Homologous Recombination Deficiency","has_exemption":false,"start_date":"2024-03-05","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06024473","publication_url":"https://clinicaltrials.gov/study/NCT06024473","title":"A rTMS and Virtual Reality Based Cognitive Rehabilitation Program for MCI","has_exemption":false,"start_date":"2024-03-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Central Arkansas Veterans Healthcare System","sponsor_slug":"central-arkansas-veterans-healthcare-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06309056","publication_url":"https://clinicaltrials.gov/study/NCT06309056","title":"Evaluating the Effectiveness of Neuromuscular Electrical Stimulation for Children With Dysphagia: A Pilot Study","has_exemption":false,"start_date":"2024-03-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Sir Mortimer B. Davis - Jewish General Hospital","sponsor_slug":"sir-mortimer-b-davis-jewish-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06269146","publication_url":"https://clinicaltrials.gov/study/NCT06269146","title":"Targeting Dopamine-Mediated Social Reward Sensitivity to Remediate Social Disconnection","has_exemption":false,"start_date":"2024-05-13","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06382168","publication_url":"https://clinicaltrials.gov/study/NCT06382168","title":"Phase I/II Study of DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia","has_exemption":false,"start_date":"2024-06-12","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Delta-Fly Pharma, Inc.","sponsor_slug":"delta-fly-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06462586","publication_url":"https://clinicaltrials.gov/study/NCT06462586","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Lumateperone in the Acute Treatment of Patients With Manic Episodes or Manic Episodes With Mixed Features Associated With Bipolar I Disorder (Bipolar Mania)","has_exemption":false,"start_date":"2024-06-19","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Intra-Cellular Therapies, Inc.","sponsor_slug":"intra-cellular-therapies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06425900","publication_url":"https://clinicaltrials.gov/study/NCT06425900","title":"Histologic and Liquid Chromatography Mass Spectrometry (LCMS) Evaluation of the Sebaceous Gland Changes Induced by Clascoterone Cream 1%","has_exemption":false,"start_date":"2024-07-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Sun Pharmaceutical Industries Limited","sponsor_slug":"sun-pharmaceutical-industries-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06255613","publication_url":"https://clinicaltrials.gov/study/NCT06255613","title":"Belun Ring Gen3 Deep Learning Algorithms With Subxiphoid Body Sensor: Exploring Its Diagnostic Capabilities for Sleep Disordered Breathing With Analysis of Biomarker Dynamics","has_exemption":false,"start_date":"2024-07-19","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Belun Technology Company Limited","sponsor_slug":"belun-technology-company-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06525077","publication_url":"https://clinicaltrials.gov/study/NCT06525077","title":"A Double-blind, Placebo-controlled, Randomized Withdrawal, Multicenter Study of the Efficacy and Safety of FT218 in the Treatment of Idiopathic Hypersomnia (IH)","has_exemption":false,"start_date":"2024-08-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Avadel","sponsor_slug":"avadel","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06442462","publication_url":"https://clinicaltrials.gov/study/NCT06442462","title":"A Randomized, Placebo-controlled, Double-blind Phase 2 Study to Assess the Efficacy, Safety, Tolerability, and Pharmacodynamics of SPG302 in Adult Participants Diagnosed With Schizophrenia","has_exemption":false,"start_date":"2024-08-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Spinogenix","sponsor_slug":"spinogenix","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06400303","publication_url":"https://clinicaltrials.gov/study/NCT06400303","title":"KYSA-5: A Phase 1/2, Open-Label, Multicentre Study of KYV 101, an Autologous Fully Human Anti-CD19 Chimeric Antigen Receptor T Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis","has_exemption":false,"start_date":"2024-08-06","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Kyverna Therapeutics","sponsor_slug":"kyverna-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06041594","publication_url":"https://clinicaltrials.gov/study/NCT06041594","title":"Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)","has_exemption":false,"start_date":"2024-08-19","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Innova Vascular, Inc.","sponsor_slug":"innova-vascular-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06457685","publication_url":"https://clinicaltrials.gov/study/NCT06457685","title":"Pulse Intravascular Lithotripsy™ (Pulse IVL™) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling for Peripheral Artery Disease","has_exemption":false,"start_date":"2024-09-05","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Amplitude Vascular Systems, Inc.","sponsor_slug":"amplitude-vascular-systems-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06539936","publication_url":"https://clinicaltrials.gov/study/NCT06539936","title":"Regulatory Clearance of the Glide Control Strategy for Upper Limb Prostheses","has_exemption":false,"start_date":"2024-09-16","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Infinite Biomedical Technologies","sponsor_slug":"infinite-biomedical-technologies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06418308","publication_url":"https://clinicaltrials.gov/study/NCT06418308","title":"Comparison of Intrathecal Epinephrine Versus Dexmedetomidine as Adjuvants in Cesarean Section","has_exemption":false,"start_date":"2024-09-17","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06625749","publication_url":"https://clinicaltrials.gov/study/NCT06625749","title":"Early Feasibility Study to Evaluate the Safety and Effectiveness of the AccuraSee™ IOPCL for Secondary Implantation in the Capsular Bag to Improve Near and/or Intermediate Vision Following Previous Cataract Surgery","has_exemption":false,"start_date":"2024-09-23","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"OnPoint Vision Inc","sponsor_slug":"onpoint-vision-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06426602","publication_url":"https://clinicaltrials.gov/study/NCT06426602","title":"Unlocking Functional Communication for Patients With Disorders of Consciousness With Innovative Brain Computer Interface Technology","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Amy Wagner","sponsor_slug":"amy-wagner","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06636539","publication_url":"https://clinicaltrials.gov/study/NCT06636539","title":"Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device","has_exemption":false,"start_date":"2024-10-14","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Hologic, Inc.","sponsor_slug":"hologic-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06049680","publication_url":"https://clinicaltrials.gov/study/NCT06049680","title":"A Single-arm Open-label Safety Study of SMOFlipid to Evaluate the Risk of Developing Essential Fatty Acid Deficiency (EFAD) and/or Parenteral Nutrition-associated Cholestasis (PNAC) in Pediatric Patients 1 Month to 17 Years of Age and in Adult Patients, Who Are Anticipated to Need 8 Weeks or Longer of Parenteral Nutrition Treatment","has_exemption":false,"start_date":"2024-10-28","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Fresenius Kabi","sponsor_slug":"fresenius-kabi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06473103","publication_url":"https://clinicaltrials.gov/study/NCT06473103","title":"Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy","has_exemption":false,"start_date":"2024-10-29","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05484973","publication_url":"https://clinicaltrials.gov/study/NCT05484973","title":"A Post-market Multi-center Prospective Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss in Women Receiving Specific Chemotherapy Regimens for Breast Cancer Stages I-III.","has_exemption":false,"start_date":"2024-11-08","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Cooler Heads Care Inc.","sponsor_slug":"cooler-heads-care-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06374264","publication_url":"https://clinicaltrials.gov/study/NCT06374264","title":"A Single Arm, Prospective, Multi-Center, Feasibility Study to Evaluate the Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder (NMOSD) Who Have an Impaired Gait","has_exemption":false,"start_date":"2024-11-12","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"MedRhythms, Inc.","sponsor_slug":"medrhythms-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06828939","publication_url":"https://clinicaltrials.gov/study/NCT06828939","title":"Pulmonary Vein Isolation With the Single Shot Endoscopic Ultra-Compliant Pulsed Field Ablation Balloon for the Treatment of Atrial Fibrillation","has_exemption":false,"start_date":"2024-12-12","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"CardioFocus","sponsor_slug":"cardiofocus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06691113","publication_url":"https://clinicaltrials.gov/study/NCT06691113","title":"A Randomized, Double-blind, Placebo-controlled, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of Itepekimab in Participants With Inadequately Controlled Chronic Rhinosinusitis Without Nasal Polyps","has_exemption":false,"start_date":"2024-12-16","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06711588","publication_url":"https://clinicaltrials.gov/study/NCT06711588","title":"Automatic Activity-Dependent and Phase-Varying Prosthetic Foot Stiffness Modulation to Improve Balance Control in Individuals With Lower-Limb Amputations","has_exemption":false,"start_date":"2024-12-19","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Seattle Institute for Biomedical and Clinical Research","sponsor_slug":"seattle-institute-for-biomedical-and-clinical-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06671847","publication_url":"https://clinicaltrials.gov/study/NCT06671847","title":"Feasibility of 24-Weeks of At-Home Chair-Based Resistance Band Training to Improve Balance, Strength, and Bone Density in Older Adults (ChaREx Study)","has_exemption":false,"start_date":"2025-01-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06935695","publication_url":"https://clinicaltrials.gov/study/NCT06935695","title":"Surveillance Versus Prn bronChOscoPy aftEr aIrway stenTing (SCOPE-IT)","has_exemption":false,"start_date":"2025-01-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06775041","publication_url":"https://clinicaltrials.gov/study/NCT06775041","title":"A Phase 2a, Randomized, Open-Label Study to Determine the Optimal Dose and Evaluate the Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients With Hutchinson-Gilford Progeria Syndrome (HGPS)","has_exemption":false,"start_date":"2025-01-13","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"PRG Science & Technology Co., Ltd.","sponsor_slug":"prg-science-technology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06296836","publication_url":"https://clinicaltrials.gov/study/NCT06296836","title":"Effect of Continuing Versus Holding Metformin During Hospitalizations to Internal Medicine on Glucose Control, Acidosis, Abdominal Symptoms, Length of Stay, and Mortality.","has_exemption":false,"start_date":"2025-01-21","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05774665","publication_url":"https://clinicaltrials.gov/study/NCT05774665","title":"Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression","has_exemption":false,"start_date":"2025-01-30","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05232032","publication_url":"https://clinicaltrials.gov/study/NCT05232032","title":"Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.1. (Pharmacological Manipulation)","has_exemption":false,"start_date":"2025-02-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Mclean Hospital","sponsor_slug":"mclean-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06853015","publication_url":"https://clinicaltrials.gov/study/NCT06853015","title":"Effects of Twice-daily Dosing 4-AP on Functional Recovery After Spinal Cord Injury","has_exemption":false,"start_date":"2025-02-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Shirley Ryan AbilityLab","sponsor_slug":"shirley-ryan-abilitylab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06745128","publication_url":"https://clinicaltrials.gov/study/NCT06745128","title":"Tirzepatide for Individuals With Comorbid Obesity and Methamphetamine Use Disorder","has_exemption":false,"start_date":"2025-02-03","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05427695","publication_url":"https://clinicaltrials.gov/study/NCT05427695","title":"Topical Probiotic Sinus Irrigations for the Treatment of Chronic Rhinosinusitis: a Double Blinded Randomized Controlled Trial","has_exemption":false,"start_date":"2025-02-05","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06111209","publication_url":"https://clinicaltrials.gov/study/NCT06111209","title":"A Pilot Study to Evaluate the Anabolic Effect of Testosterone on Muscles of the Pelvic Floor in Older Women With Stress Urinary Incontinence","has_exemption":false,"start_date":"2025-02-15","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06144749","publication_url":"https://clinicaltrials.gov/study/NCT06144749","title":"An Open Label Phase 2a Ascending Multiple Dose Safety, Efficacy, and Pharmacokinetic Study of HBI-002 Carbon Monoxide Oral Liquid Drug Product in Adolescents and Adults With Sickle Cell Disease.","has_exemption":false,"start_date":"2025-02-15","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Hillhurst Biopharmaceuticals, Inc.","sponsor_slug":"hillhurst-biopharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05790239","publication_url":"https://clinicaltrials.gov/study/NCT05790239","title":"A Randomized, Double-Blind, Single-Site Phase II 2-Arm Study to Compare the Safety and Preliminary Efficacy of Manualized MDMA-Assisted Therapy to Low Dose D-Amphetamine Assisted Therapy in Veterans For The Treatment of Moderate to Severe PTSD","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Stephen Robert Marder","sponsor_slug":"stephen-robert-marder","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06839833","publication_url":"https://clinicaltrials.gov/study/NCT06839833","title":"A Prospective, Interventional Study to Assess the Clinical Performance of the APOL1 Genotyping Clinical Trial Assay in the Intended Use Population and Environment","has_exemption":false,"start_date":"2025-03-06","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Almac Diagnostic Services LLC","sponsor_slug":"almac-diagnostic-services-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06578624","publication_url":"https://clinicaltrials.gov/study/NCT06578624","title":"A Phase 1/2a, Open-Label Study of Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SA53-OS, an MDM2 Inhibitor, in Patients With Locally Advanced or Metastatic p53 Wild-Type Solid Tumors","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Lamassu Bio Inc","sponsor_slug":"lamassu-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06885073","publication_url":"https://clinicaltrials.gov/study/NCT06885073","title":"Non-invasive Central Venous Pressure Estimation in Pediatric Patients","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Compremium AG","sponsor_slug":"compremium-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06696118","publication_url":"https://clinicaltrials.gov/study/NCT06696118","title":"Electromagnetic Transduction Therapy (EMTT) on Mid-foot Osteoarthritis: A Pilot Study","has_exemption":false,"start_date":"2025-03-13","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07264205","publication_url":"https://clinicaltrials.gov/study/NCT07264205","title":"Safety and Feasibility Study of RT-310 for Treatment of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)","has_exemption":false,"start_date":"2025-03-13","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Resurge Therapeutics Inc.","sponsor_slug":"resurge-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06903767","publication_url":"https://clinicaltrials.gov/study/NCT06903767","title":"Do Quantifiable Differences in Physiologic Stress Exist in Surgeons When Comparing the Use of a Powered Femoral Impactor Versus Manual Impaction in Total Hip Arthroplasty?","has_exemption":false,"start_date":"2025-03-25","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Rothman Institute Orthopaedics","sponsor_slug":"rothman-institute-orthopaedics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06824454","publication_url":"https://clinicaltrials.gov/study/NCT06824454","title":"Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06872801","publication_url":"https://clinicaltrials.gov/study/NCT06872801","title":"Comparison of the Effects of Home High-Flow Nasal Cannula Therapy and Noninvasive Ventilation in Patients With Stable Chronic Hypercapnic Respiratory Failure","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Wonju Severance Christian Hospital","sponsor_slug":"wonju-severance-christian-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06664775","publication_url":"https://clinicaltrials.gov/study/NCT06664775","title":"An Open Label, Prospective, Randomized, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of TachoSil® Versus Surgicel™ Original (Oxidized Regenerated Cellulose) as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery.","has_exemption":false,"start_date":"2025-04-02","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Corza Medical GmbH","sponsor_slug":"corza-medical-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06664788","publication_url":"https://clinicaltrials.gov/study/NCT06664788","title":"A Prospective, Multicenter, Randomized Clinical Investigation Evaluating the Safety and Efficacy of ETHIZIA™ Versus SURGICEL® Original in Controlling Minimal, Mild, or Moderate Soft Tissue Bleeding During Open Abdominal, Retroperitoneal, Pelvic, Thoracic (Non-cardiac) and Extremity Surgery","has_exemption":false,"start_date":"2025-04-16","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Ethicon, Inc.","sponsor_slug":"ethicon-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06747468","publication_url":"https://clinicaltrials.gov/study/NCT06747468","title":"A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Avexitide in Participants With Post-Bariatric Hypoglycemia","has_exemption":false,"start_date":"2025-04-29","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Amylyx Pharmaceuticals Inc.","sponsor_slug":"amylyx-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06831422","publication_url":"https://clinicaltrials.gov/study/NCT06831422","title":"Application of a Novel Antimicrobial Wash Versus Hydrogen Peroxide Versus Povidone-iodine to the Dermis and Incidence of Cutibacterium Acnes During Shoulder Arthroplasty: A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-05-05","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Henry Ford Health System","sponsor_slug":"henry-ford-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07223632","publication_url":"https://clinicaltrials.gov/study/NCT07223632","title":"The Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient With Confirmed IGHMBP2 Intronic Cryptic Splice Variant C. 1235+894C>A That is Amenable to Antisense Oligonucleotide (ASO)-Mediated Correction of IGHMBP2 Splicing","has_exemption":false,"start_date":"2025-05-13","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Vanda Pharmaceuticals","sponsor_slug":"vanda-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07041073","publication_url":"https://clinicaltrials.gov/study/NCT07041073","title":"Restoring Emotional Stability Through Neurofeedback and AI for Transformative Empowerment","has_exemption":false,"start_date":"2025-05-19","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Corporacion Parc Tauli","sponsor_slug":"corporacion-parc-tauli","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07047209","publication_url":"https://clinicaltrials.gov/study/NCT07047209","title":"A Phase 2a Biomarker-Driven Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS) - The Acacia Trial, an ALS MyMatch Trial","has_exemption":false,"start_date":"2025-05-27","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06701071","publication_url":"https://clinicaltrials.gov/study/NCT06701071","title":"Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation in Patients With Diminished Ovarian Reserve Undergoing In-vitro Fertilization: a Randomized Controlled Trial","has_exemption":false,"start_date":"2025-06-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222280","publication_url":"https://clinicaltrials.gov/study/NCT07222280","title":"Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy","has_exemption":false,"start_date":"2025-06-10","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Covenant Health, US","sponsor_slug":"covenant-health-us","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06998043","publication_url":"https://clinicaltrials.gov/study/NCT06998043","title":"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects With Chronic Pseudomonas Aeruginosa (PsA) Pulmonary Infection","has_exemption":false,"start_date":"2025-07-02","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"BiomX Ltd","sponsor_slug":"biomx-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07095920","publication_url":"https://clinicaltrials.gov/study/NCT07095920","title":"Frequency-tuned Electromagnetic Field Treatment to Facilitate Recovery of Patients With Chronic Stroke","has_exemption":false,"start_date":"2025-08-27","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06798675","publication_url":"https://clinicaltrials.gov/study/NCT06798675","title":"A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE-RANGING CLINICAL TRIAL TO EVALUATE THE PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF nC-001 IN PATIENTS WITH CHRONIC EUVOLEMIC HYPONATREMIA","has_exemption":false,"start_date":"2025-08-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"nephCentric","sponsor_slug":"nephcentric","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07140783","publication_url":"https://clinicaltrials.gov/study/NCT07140783","title":"RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-MASKED STUDY OF THE SAFETY AND EFFICACY OF POS (0.75% PHENTOLAMINE OPHTHALMIC SOLUTION) IN PARTICIPANTS WITH PREVIOUS KERATOREFRACTIVE SURGERY WITH DECREASED VISUAL ACUITY UNDER MESOPIC CONDITIONS","has_exemption":false,"start_date":"2025-09-02","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Ocuphire Pharma, Inc.","sponsor_slug":"ocuphire-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06591091","publication_url":"https://clinicaltrials.gov/study/NCT06591091","title":"Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression","has_exemption":false,"start_date":"2025-09-30","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07090811","publication_url":"https://clinicaltrials.gov/study/NCT07090811","title":"Streamlined One-wire Logistics Optimize Transcatheter Aortic Valve Replacement","has_exemption":false,"start_date":"2025-09-30","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Solo Pace, Inc.","sponsor_slug":"solo-pace-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07096934","publication_url":"https://clinicaltrials.gov/study/NCT07096934","title":"A Prospective, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care","has_exemption":false,"start_date":"2025-09-30","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"FibroBiologics","sponsor_slug":"fibrobiologics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07124130","publication_url":"https://clinicaltrials.gov/study/NCT07124130","title":"Parenteral Lactated Ringer's Plus Dextrose 5% vs Lactated Ringer's in Labor: A Randomized Control Trial on Maternal and Neonatal Outcomes","has_exemption":false,"start_date":"2025-09-30","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Eastern Virginia Medical School","sponsor_slug":"eastern-virginia-medical-school","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05621538","publication_url":"https://clinicaltrials.gov/study/NCT05621538","title":"A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Auburn University","sponsor_slug":"auburn-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07205120","publication_url":"https://clinicaltrials.gov/study/NCT07205120","title":"Fluid Guided Heart Failure Treatment","has_exemption":false,"start_date":"2025-10-08","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Bodyport Inc.","sponsor_slug":"bodyport-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217613","publication_url":"https://clinicaltrials.gov/study/NCT07217613","title":"Prospective Evaluation of Silk Fibroin Incision Dressings in ACL Reconstruction: A Biocompatible Alternative for High-Motion Surgical Sites","has_exemption":false,"start_date":"2025-10-14","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217353","publication_url":"https://clinicaltrials.gov/study/NCT07217353","title":"The Use of a Novel Vaginal Speculum for Endometrial Biopsies","has_exemption":false,"start_date":"2025-10-15","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Rocky Vista University, LLC","sponsor_slug":"rocky-vista-university-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07189013","publication_url":"https://clinicaltrials.gov/study/NCT07189013","title":"Assessing Patient Preference for Infusion Systems (Electronic vs. Mechanical)","has_exemption":false,"start_date":"2025-10-15","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"KORU Medical Systems, Inc.","sponsor_slug":"koru-medical-systems-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07085416","publication_url":"https://clinicaltrials.gov/study/NCT07085416","title":"Sensor Ankle Brace for Special Operations Rehabilitation","has_exemption":false,"start_date":"2025-10-16","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07209163","publication_url":"https://clinicaltrials.gov/study/NCT07209163","title":"An Open-label, Single-arm Study Evaluating the Safety and Efficacy of Tazemetostat in Combination With Linperlisib/Golidocitinib in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma","has_exemption":false,"start_date":"2025-10-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Ruijin Hospital","sponsor_slug":"ruijin-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07210697","publication_url":"https://clinicaltrials.gov/study/NCT07210697","title":"Orthodontic Pain Alleviation With Chewing Gum","has_exemption":false,"start_date":"2025-10-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07212803","publication_url":"https://clinicaltrials.gov/study/NCT07212803","title":"Evaluation of Energy Drinks on Electrocardiographic Parameters: A Randomized, Double Blind, Controlled, Crossover, Proof-of-concept Study","has_exemption":false,"start_date":"2025-11-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of the Pacific","sponsor_slug":"university-of-the-pacific","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07228325","publication_url":"https://clinicaltrials.gov/study/NCT07228325","title":"A Comparison of PK and PD Responses Following Single and Repeat Administration of Epinephrine Nasal FMXIN002 4.0 mg and EpiPen 0.3 mg, in Healthy Adults With Allergic Rhinitis","has_exemption":false,"start_date":"2025-11-03","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Nasus Pharma","sponsor_slug":"nasus-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06979726","publication_url":"https://clinicaltrials.gov/study/NCT06979726","title":"Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure","has_exemption":false,"start_date":"2025-11-20","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221994","publication_url":"https://clinicaltrials.gov/study/NCT07221994","title":"The Effects of Blood Flow Restriction Combined With Low-Intensity Recumbent Stepping in Individuals With Advanced Parkinson's Disease","has_exemption":false,"start_date":"2025-11-21","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05948579","publication_url":"https://clinicaltrials.gov/study/NCT05948579","title":"A Phase 2, Multi-center, Multi-arm, Randomized, Placebo-controlled, Double-blind, Adaptive Platform Study to Evaluate the Safety, Tolerability, and Efficacy of Potential Pharmacotherapeutic Interventions in Active-Duty Service Members and Veterans With PTSD","has_exemption":false,"start_date":"2025-11-30","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Global Coalition for Adaptive Research","sponsor_slug":"global-coalition-for-adaptive-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06816433","publication_url":"https://clinicaltrials.gov/study/NCT06816433","title":"A Phase 2, Multi-center, Multi-arm, Randomized, Placebo-controlled, Double-blind, Adaptive Platform Study to Evaluate the Safety, Tolerability, and Efficacy of Potential Pharmacotherapeutic Interventions in Active-Duty Service Members and Veterans With PTSD","has_exemption":false,"start_date":"2025-11-30","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Global Coalition for Adaptive Research","sponsor_slug":"global-coalition-for-adaptive-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07263698","publication_url":"https://clinicaltrials.gov/study/NCT07263698","title":"Investigation of Clinical Efficacy of a New Mouthwash on Reducing Dental Plaque and Helping Prevent Gum Problems as Compared to a Control Mouthwash - a Three-month Study in Italy","has_exemption":false,"start_date":"2025-12-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Colgate Palmolive","sponsor_slug":"colgate-palmolive","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07393334","publication_url":"https://clinicaltrials.gov/study/NCT07393334","title":"Effects of NLS-133, a Potential Non-Hormonal \"On-Demand\" Male Contraceptive, on Semen Volume and Sperm Count in Normal Men: A Double-Blind, Placebo-Controlled Trial","has_exemption":false,"start_date":"2025-12-02","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Next Life Sciences","sponsor_slug":"next-life-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07296419","publication_url":"https://clinicaltrials.gov/study/NCT07296419","title":"Dual System Study: Transvaginal Fetal Pulse Oximetry Measurement Systems","has_exemption":false,"start_date":"2025-12-08","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Raydiant Oximetry, Inc.","sponsor_slug":"raydiant-oximetry-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07321938","publication_url":"https://clinicaltrials.gov/study/NCT07321938","title":"Accuracy Evaluation of the Owlet OSS 3.0-M1 Sensor in Toddlers and Preschoolers","has_exemption":false,"start_date":"2025-12-15","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Owlet Baby Care, Inc.","sponsor_slug":"owlet-baby-care-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07021729","publication_url":"https://clinicaltrials.gov/study/NCT07021729","title":"Comparison of Conventional Clarithromycin Vs Alternative Levofloxacin Based Regimen in Treatment of Helicobacter Pylori Infection","has_exemption":false,"start_date":"2025-12-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Rehman Medical Institute - RMI","sponsor_slug":"rehman-medical-institute-rmi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07298434","publication_url":"https://clinicaltrials.gov/study/NCT07298434","title":"A Phase 3, Randomized, Triple-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VYD2311 for the Prevention of COVID-19 in Adults and Adolescents","has_exemption":false,"start_date":"2026-01-08","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Invivyd, Inc.","sponsor_slug":"invivyd-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07369180","publication_url":"https://clinicaltrials.gov/study/NCT07369180","title":"Safety and Efficacy of an Accelerated, Rectangular Waveform rTMS Protocol in Treatment of Adults With Major Depressive Disorder.","has_exemption":false,"start_date":"2026-01-15","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"NeuroQore Inc.","sponsor_slug":"neuroqore-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07397078","publication_url":"https://clinicaltrials.gov/study/NCT07397078","title":"Moni-Patch Temperature Monitoring Patch System Clinical Accuracy Validation","has_exemption":false,"start_date":"2026-01-21","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Murata Vios, Inc.","sponsor_slug":"murata-vios-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06906471","publication_url":"https://clinicaltrials.gov/study/NCT06906471","title":"A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS","has_exemption":false,"start_date":"2026-02-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Antelope Surgical Solutions, Inc","sponsor_slug":"antelope-surgical-solutions-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04637282","publication_url":"https://clinicaltrials.gov/study/NCT04637282","title":"A Randomized. Multicenter, Double-Blind, Placebo-Controlled Safety, Tolerability, and Efficacy Study of PLX-200 in Participants With Mild-to-Moderate Juvenile Neuronal Ceroid Lipofuscinosis (CLN3) Disease","has_exemption":false,"start_date":"2026-03-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Polaryx Therapeutics, Inc.","sponsor_slug":"polaryx-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06723171","publication_url":"https://clinicaltrials.gov/study/NCT06723171","title":"A 4-Week, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of the RXR Agonist Compound IRX4204 for the Treatment of Mild to Moderate Plaque Psoriasis","has_exemption":false,"start_date":"2026-03-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Io Therapeutics","sponsor_slug":"io-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02177292","publication_url":"https://clinicaltrials.gov/study/NCT02177292","title":"A Phase II Trial of High-Dose Pelvic Lymph Node IMRT( Intensity Modulated Radiation Therapy) and Hypofractionated Prostate IMRT for High Risk Prostate Cancer Patients","has_exemption":false,"start_date":"2010-06-23","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03471117","publication_url":"https://clinicaltrials.gov/study/NCT03471117","title":"Targeting ADMA With Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients","has_exemption":false,"start_date":"2018-04-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas at Arlington","sponsor_slug":"the-university-of-texas-at-arlington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03400215","publication_url":"https://clinicaltrials.gov/study/NCT03400215","title":"Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer","has_exemption":false,"start_date":"2018-07-23","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03809533","publication_url":"https://clinicaltrials.gov/study/NCT03809533","title":"Transplantation of Kidneys of Hepatitis C (HCV) Seropositive Donors to HCV Seronegative Recipients With Subsequent Therapy With Sofosbuvir/Velpatasvir (Epclusa)","has_exemption":false,"start_date":"2019-05-29","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Amit D Tevar, MD","sponsor_slug":"amit-d-tevar-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04065438","publication_url":"https://clinicaltrials.gov/study/NCT04065438","title":"Treatment of Drug-resistant Adult and Pediatrc Primary Focal Segmental Glomerulosclerosis and Post -Transplant Recurrence Using the LIPOSORBER® LA-15 System","has_exemption":false,"start_date":"2020-01-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Kaneka Medical America LLC","sponsor_slug":"kaneka-medical-america-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04315571","publication_url":"https://clinicaltrials.gov/study/NCT04315571","title":"Effective Ascites ReLief In earlY TIPS (EARLY TIPS) Using Viatorr CX vs. LVP Study","has_exemption":false,"start_date":"2020-03-24","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04278768","publication_url":"https://clinicaltrials.gov/study/NCT04278768","title":"A Phase 1/2A, Open Label Dose Escalation and Expansion Study of Orally Administered CA-4948 as a Monotherapy in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome","has_exemption":false,"start_date":"2020-07-06","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Curis, Inc.","sponsor_slug":"curis-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04462770","publication_url":"https://clinicaltrials.gov/study/NCT04462770","title":"A 20-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children and Adult Participants With Dravet Syndrome (ARGUS Trial)","has_exemption":false,"start_date":"2020-09-15","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Epygenix","sponsor_slug":"epygenix","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04899310","publication_url":"https://clinicaltrials.gov/study/NCT04899310","title":"A Global Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of mRNA-3705 in Participants With Isolated Methylmalonic Acidemia Due to Methylmalonyl-CoA Mutase Deficiency","has_exemption":false,"start_date":"2021-08-06","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04812366","publication_url":"https://clinicaltrials.gov/study/NCT04812366","title":"Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer","has_exemption":false,"start_date":"2021-09-21","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"University of British Columbia","sponsor_slug":"university-of-british-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04724447","publication_url":"https://clinicaltrials.gov/study/NCT04724447","title":"EXPERIMENTAL ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION: AFFECTIVE, NEURAL, AND INFLAMMATORY MECHANISMS","has_exemption":false,"start_date":"2021-11-23","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Laureate Institute for Brain Research, Inc.","sponsor_slug":"laureate-institute-for-brain-research-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04899687","publication_url":"https://clinicaltrials.gov/study/NCT04899687","title":"Fluoxetine/Dextromethorphan in Obsessive-Compulsive and Related Disorders: an Open-Label Crossover Pilot Study","has_exemption":false,"start_date":"2022-01-20","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05236010","publication_url":"https://clinicaltrials.gov/study/NCT05236010","title":"Control Network Neuromodulation to Enhance Cognitive Training in Complex Traumatic Brain Injury","has_exemption":false,"start_date":"2022-01-21","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"University of New Mexico","sponsor_slug":"university-of-new-mexico","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04580134","publication_url":"https://clinicaltrials.gov/study/NCT04580134","title":"Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (Clozapine)","has_exemption":false,"start_date":"2022-03-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05388123","publication_url":"https://clinicaltrials.gov/study/NCT05388123","title":"A Single Arm Phase II Pilot Study of Low Dose Vemurafenib Plus Rituximab in the Front-line and Relapsed/Refractory Treatment of Hairy Cell Leukemia","has_exemption":false,"start_date":"2022-03-02","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Scripps Health","sponsor_slug":"scripps-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04460521","publication_url":"https://clinicaltrials.gov/study/NCT04460521","title":"The Use of N-acetylcysteine Supplementation in Addition to Night Splinting for Treatment of Mild to Moderate Carpal Tunnel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial","has_exemption":false,"start_date":"2022-04-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Emily Krauss","sponsor_slug":"emily-krauss","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05898087","publication_url":"https://clinicaltrials.gov/study/NCT05898087","title":"Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty","has_exemption":false,"start_date":"2022-04-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Connecticut Children's Medical Center","sponsor_slug":"connecticut-childrens-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05319873","publication_url":"https://clinicaltrials.gov/study/NCT05319873","title":"A Phase 1B Trial Evaluating the Safety of Ribociclib, Tucatinib, and Trastuzumab in Patients With Metastatic, HER2+ Breast Cancer and a Multicenter, Randomized, Open-Label, Phase 2 Study of Preoperative Treatment With Ribociclib,Ttrastuzumab, Tucatinib, and Fulvestrant Versus Docetaxel, Carboplatin,Ttrastuzumab, and Pertuzumab in HR+/HER2+ Breast Cancer and Ribociclib, Trastuzumab, and Tucatinib Versus Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab in Patients With HR-/HER2+ Breast Cancer","has_exemption":false,"start_date":"2022-04-07","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05237869","publication_url":"https://clinicaltrials.gov/study/NCT05237869","title":"Blood Flow Restricted Training to Enhance Lateral Epicondylitis Rehabilitation.","has_exemption":false,"start_date":"2022-05-20","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Julie Nuelle","sponsor_slug":"julie-nuelle","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05443685","publication_url":"https://clinicaltrials.gov/study/NCT05443685","title":"An Open-Label, Phase 1/2, Single-Site Study of the Safety, Biochemical Efficacy, and Exploratory Clinical Effects of Oral ADX-629 in Subjects With Sjögren-Larsson Syndrome","has_exemption":false,"start_date":"2023-01-02","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05419518","publication_url":"https://clinicaltrials.gov/study/NCT05419518","title":"Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metastases","has_exemption":false,"start_date":"2023-03-16","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05649722","publication_url":"https://clinicaltrials.gov/study/NCT05649722","title":"An Open-Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease","has_exemption":false,"start_date":"2023-05-11","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Insmed Incorporated","sponsor_slug":"insmed-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06064890","publication_url":"https://clinicaltrials.gov/study/NCT06064890","title":"A Phase 1/2 Open-Label, Ascending Dose, Multicenter Study to Evaluate the Safety and Preliminary Efficacy of AVB-101 Administered by Bilateral Intrathalamic Infusion in Subjects With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)","has_exemption":false,"start_date":"2023-08-30","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"AviadoBio Ltd","sponsor_slug":"aviadobio-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05555056","publication_url":"https://clinicaltrials.gov/study/NCT05555056","title":"Enhancing the Effectiveness of Cognitive Behavioral Therapy Using Non-invasive Brain Stimulation","has_exemption":false,"start_date":"2023-09-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"University of Manitoba","sponsor_slug":"university-of-manitoba","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05683834","publication_url":"https://clinicaltrials.gov/study/NCT05683834","title":"A Phase 1/2 Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-Seronegative Persons","has_exemption":false,"start_date":"2023-09-22","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06062446","publication_url":"https://clinicaltrials.gov/study/NCT06062446","title":"A Prospective, Single-Arm Study of a Modified Lumbar Puncture (LP) Procedure That Reduces Post-Lumbar Puncture Headaches (PLPH) in Adult Patients","has_exemption":false,"start_date":"2023-11-08","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06167733","publication_url":"https://clinicaltrials.gov/study/NCT06167733","title":"Safety and Efficacy Assessment of the VERTICA® - a Radio Frequency Device for the Treatment of Erectile Dysfunction","has_exemption":false,"start_date":"2023-11-29","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"OHH-MED Medical Ltd","sponsor_slug":"ohh-med-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06033586","publication_url":"https://clinicaltrials.gov/study/NCT06033586","title":"An Extension Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera (THRIVE)","has_exemption":false,"start_date":"2024-01-22","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Protagonist Therapeutics, Inc.","sponsor_slug":"protagonist-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06034938","publication_url":"https://clinicaltrials.gov/study/NCT06034938","title":"DOR/TDF/3TC Maintenance Therapy Among Patients Harboring M184V/I Mutation: a Pilot Open-label Study","has_exemption":false,"start_date":"2024-02-08","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"University Hospital, Caen","sponsor_slug":"university-hospital-caen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06305793","publication_url":"https://clinicaltrials.gov/study/NCT06305793","title":"RECOVER-AUTONOMIC (IVIG): Randomized Trial of the Effect of IVIG Versus Placebo on Long COVID Symptoms","has_exemption":false,"start_date":"2024-03-11","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Kanecia Obie Zimmerman","sponsor_slug":"kanecia-obie-zimmerman","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06619301","publication_url":"https://clinicaltrials.gov/study/NCT06619301","title":"Randomized Controlled Trial of Glargine Versus Neutral Protamine Hagedorn Insulin for the Treatment of Diabetes Mellitus in Pregnancy","has_exemption":false,"start_date":"2024-04-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Loyola University","sponsor_slug":"loyola-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06351683","publication_url":"https://clinicaltrials.gov/study/NCT06351683","title":"Mito-LUTS: A Pilot Study of the Effect of MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome","has_exemption":false,"start_date":"2024-04-03","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Iman Al-Naggar, PhD","sponsor_slug":"iman-al-naggar-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06239818","publication_url":"https://clinicaltrials.gov/study/NCT06239818","title":"Assessing the Effects of Photobiomodulation on Clinical Recovery From Concussion in Adolescents","has_exemption":false,"start_date":"2024-04-17","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06267391","publication_url":"https://clinicaltrials.gov/study/NCT06267391","title":"A Multicenter, Randomized, Double-blind, Sham-controlled Study for Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes (ReCET Study)","has_exemption":false,"start_date":"2024-05-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Endogenex, Inc.","sponsor_slug":"endogenex-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06314061","publication_url":"https://clinicaltrials.gov/study/NCT06314061","title":"The Effect of Continuous Glucose Monitoring With Real-time Alerts on Glycaemic Control in Surgical Patients With Diabetes: A Randomised, Clinical Multicentre Trial","has_exemption":false,"start_date":"2024-06-24","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Christian S. Meyhoff","sponsor_slug":"christian-s-meyhoff","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06625398","publication_url":"https://clinicaltrials.gov/study/NCT06625398","title":"REVEAL-2 - A Phase 3, Randomized, Double-masked, Placebo-controlled, Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)","has_exemption":false,"start_date":"2024-08-27","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Viridian Therapeutics, Inc.","sponsor_slug":"viridian-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06736964","publication_url":"https://clinicaltrials.gov/study/NCT06736964","title":"Clinical Evaluation of Different Bioactive Restorative Materials for Cervical Carious in High Caries Risk Patients :A Randomized Clinical Trial","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Cairo University","sponsor_slug":"cairo-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06218030","publication_url":"https://clinicaltrials.gov/study/NCT06218030","title":"PSIY-744-23: Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study","has_exemption":false,"start_date":"2024-10-22","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Queen's University","sponsor_slug":"queens-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06694077","publication_url":"https://clinicaltrials.gov/study/NCT06694077","title":"Comparative Study of Dexamethasone Plus Bupivacaine Versus Bupivacaine in Suprazygomatic Maxillary Nerve Block for Management of Postoperative Pain in Adenotonsillectomy Patients","has_exemption":false,"start_date":"2024-12-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06938867","publication_url":"https://clinicaltrials.gov/study/NCT06938867","title":"A Phase 1b/2a, Randomized, Double-blind Study to Investigate Safety, Tolerability, PK, PD, and Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplantation Receiving Fluoroquinolone Prophylaxis and Harboring Fluoroquinolone-Resistant Escherichia Coli Pre-Transplant","has_exemption":false,"start_date":"2025-02-25","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"SNIPR Biome Aps.","sponsor_slug":"snipr-biome-aps","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06158620","publication_url":"https://clinicaltrials.gov/study/NCT06158620","title":"Intra-nasal Ketorolac Versus Oral Diclofenac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07046806","publication_url":"https://clinicaltrials.gov/study/NCT07046806","title":"Oral Deucrictibant for the Prophylactic and Acute Treatment in Patients With Bradykinin Mediated Angioedema With Normal C1 Inhibitor (BK-AE-nC1INH)","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Institute for Asthma and Allergy","sponsor_slug":"institute-for-asthma-and-allergy","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06692907","publication_url":"https://clinicaltrials.gov/study/NCT06692907","title":"A Phase 2b, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy of Intramuscularly Administered CssBA+dmLT Against Moderate-severe Diarrhea in a Controlled Human Infection Model With Enterotoxigenic Escherichia Coli (ETEC) Strain B7A in Healthy Adults","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06809725","publication_url":"https://clinicaltrials.gov/study/NCT06809725","title":"Validation of the SPARK Scan Cognitive Status Indicator Software Concordance With Clinical Diagnosis in Humans With Unimpaired, Mild Cognitive Impairment and Dementia Status, With and Without Alzheimer's Disease","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Spark Neuro Inc.","sponsor_slug":"spark-neuro-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06682299","publication_url":"https://clinicaltrials.gov/study/NCT06682299","title":"Transitioning From Maintenance ECT to Maintenance TMS in Treatment Resistant Depression","has_exemption":false,"start_date":"2025-04-17","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Austin Messner","sponsor_slug":"austin-messner","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06874101","publication_url":"https://clinicaltrials.gov/study/NCT06874101","title":"Evaluating a Respiratory Oxygen Adherence Monitor for COPD Patients With Long-term Oxygen Therapy","has_exemption":false,"start_date":"2025-05-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Barron Associates, Inc.","sponsor_slug":"barron-associates-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06883123","publication_url":"https://clinicaltrials.gov/study/NCT06883123","title":"Efficacy and Tolerability of Simbrinza and Rocklatan vs. Cosopt","has_exemption":false,"start_date":"2025-05-14","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Prairie Eye Center","sponsor_slug":"prairie-eye-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06933381","publication_url":"https://clinicaltrials.gov/study/NCT06933381","title":"Topical Vapocoolant to Reduce Pain With Nexplanon Insertion: A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-06-16","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Queen's Medical Center","sponsor_slug":"queens-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06865144","publication_url":"https://clinicaltrials.gov/study/NCT06865144","title":"Prospective, Randomized, Double- Masked Study to Evaluate the Effect of Rhopressa Versus Placebo on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-Selective Laser Trabeculoplasty (SLT)","has_exemption":false,"start_date":"2025-06-27","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"East Coast Institute for Research","sponsor_slug":"east-coast-institute-for-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06986824","publication_url":"https://clinicaltrials.gov/study/NCT06986824","title":"A Pilot Study To Assess The Effect Of Antepartum Perineal Massage Using A Pelvic Wand On Labor Agency And Pelvic Health","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07461389","publication_url":"https://clinicaltrials.gov/study/NCT07461389","title":"Effects of Pre-procedure and Intra-procedure Simethicone and Dicyclomine Administration in Improving Quality of Endoscopic Reterograde Cholangipancreaticography (ERCP)","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"CMH Lahore Medical College and Institute of Dentistry","sponsor_slug":"cmh-lahore-medical-college-and-institute-of-dentistry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06893341","publication_url":"https://clinicaltrials.gov/study/NCT06893341","title":"Monitoring Volatile Organic Compound Profiles in Exhaled Breath to Noninvasively Detect Glycemic Events in Patients With Diabetes","has_exemption":false,"start_date":"2025-10-23","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06023043","publication_url":"https://clinicaltrials.gov/study/NCT06023043","title":"A Randomized Trial of Postoperative Steroid Use Following Posterior Spinal Fusion in 100-subject Adolescent Idiopathic Scoliosis (AIS) and Neuromuscular Scoliosis (NMS)","has_exemption":false,"start_date":"2025-11-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Los Angeles","sponsor_slug":"childrens-hospital-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217639","publication_url":"https://clinicaltrials.gov/study/NCT07217639","title":"Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings","has_exemption":false,"start_date":"2025-11-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Aptitude Medical Systems","sponsor_slug":"aptitude-medical-systems","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07132177","publication_url":"https://clinicaltrials.gov/study/NCT07132177","title":"Targeted Naltrexone to Support Individuals Participating in Dry January","has_exemption":false,"start_date":"2025-11-03","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222722","publication_url":"https://clinicaltrials.gov/study/NCT07222722","title":"Near Infrared Spectroscopy (NIRS) Monitoring as an Early Predictor of Acute Kidney Injury (AKI) in a Vulnerable Neonatal Intensive Care Unit (NICU) Population","has_exemption":false,"start_date":"2025-11-30","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07267299","publication_url":"https://clinicaltrials.gov/study/NCT07267299","title":"Efficacy of Switching Participants Treated With Restasis to TRYPTYR","has_exemption":false,"start_date":"2025-12-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Southern College of Optometry","sponsor_slug":"southern-college-of-optometry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05517447","publication_url":"https://clinicaltrials.gov/study/NCT05517447","title":"An Open-label Extension Study for Participants Who Completed Study IMVT-1401-3201 or Study IMVT-1401-3202 to Assess the Efficacy and Safety of Batoclimab for the Treatment of Thyroid Eye Disease (TED)","has_exemption":false,"start_date":"2022-11-06","completion_date":"2026-04-02","has_results":false,"results_due":false,"sponsor_name":"Immunovant Sciences GmbH","sponsor_slug":"immunovant-sciences-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06172257","publication_url":"https://clinicaltrials.gov/study/NCT06172257","title":"A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS 01 Eye Drops in Subjects With Diabetic Macular Edema","has_exemption":false,"start_date":"2024-03-15","completion_date":"2026-04-02","has_results":false,"results_due":false,"sponsor_name":"Oculis","sponsor_slug":"oculis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03250338","publication_url":"https://clinicaltrials.gov/study/NCT03250338","title":"Phase III Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy of the Addition of Crenolanib to Salvage Chemotherapy Versus Salvage Chemotherapy Alone in Subjects ≤ 75 Years of Age With Relapsed/Refractory FLT3 Mutated Acute Myeloid Leukemia","has_exemption":false,"start_date":"2018-08-16","completion_date":"2026-04-03","has_results":false,"results_due":false,"sponsor_name":"Arog Pharmaceuticals, Inc.","sponsor_slug":"arog-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04384692","publication_url":"https://clinicaltrials.gov/study/NCT04384692","title":"Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis","has_exemption":false,"start_date":"2020-12-18","completion_date":"2026-04-03","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05253651","publication_url":"https://clinicaltrials.gov/study/NCT05253651","title":"An Open-label Randomized Phase 3 Study of Tucatinib in Combination With Trastuzumab and mFOLFOX6 Versus mFOLFOX6 Given With or Without Either Cetuximab or Bevacizumab as First-line Treatment for Subjects With HER2+ Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2022-10-24","completion_date":"2026-04-03","has_results":false,"results_due":false,"sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","sponsor_slug":"seagen-a-wholly-owned-subsidiary-of-pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05237388","publication_url":"https://clinicaltrials.gov/study/NCT05237388","title":"Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease","has_exemption":false,"start_date":"2023-04-20","completion_date":"2026-04-03","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06695130","publication_url":"https://clinicaltrials.gov/study/NCT06695130","title":"A Phase 1/2, Parallel, Randomized, Modified Double-blind, Multi-arm Study to Assess the Safety and Immunogenicity of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older","has_exemption":false,"start_date":"2024-11-18","completion_date":"2026-04-03","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06702878","publication_url":"https://clinicaltrials.gov/study/NCT06702878","title":"A Group-Randomized, Standard-of-Care-Controlled, Crossover Trial Evaluating Nasal Antimicrobial Photodisinfection for the Prevention of Surgical Site Infections","has_exemption":false,"start_date":"2024-12-27","completion_date":"2026-04-03","has_results":false,"results_due":false,"sponsor_name":"Ondine Biomedical Inc.","sponsor_slug":"ondine-biomedical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06794866","publication_url":"https://clinicaltrials.gov/study/NCT06794866","title":"A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of OnabotulinumtoxinA Purified Neurotoxin Complex for the Treatment of Moderate to Severe Forehead Lines in Japan","has_exemption":false,"start_date":"2025-01-22","completion_date":"2026-04-03","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04669457","publication_url":"https://clinicaltrials.gov/study/NCT04669457","title":"Prevention of Emergence Delirium in Pediatric Ambulatory Surgery: Single Blinded Randomized Control Study Comparing Intra-nasal Dexmedetomidine With Oral Midazolam.","has_exemption":false,"start_date":"2021-04-27","completion_date":"2026-04-05","has_results":false,"results_due":false,"sponsor_name":"University of Massachusetts, Worcester","sponsor_slug":"university-of-massachusetts-worcester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05967585","publication_url":"https://clinicaltrials.gov/study/NCT05967585","title":"Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics","has_exemption":false,"start_date":"2023-08-04","completion_date":"2026-04-05","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03172754","publication_url":"https://clinicaltrials.gov/study/NCT03172754","title":"Phase I/II Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma","has_exemption":false,"start_date":"2017-06-12","completion_date":"2026-04-06","has_results":false,"results_due":false,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03258931","publication_url":"https://clinicaltrials.gov/study/NCT03258931","title":"Phase III Randomized Study of Crenolanib Versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects With FLT3 Mutated Acute Myeloid Leukemia","has_exemption":false,"start_date":"2018-08-15","completion_date":"2026-04-06","has_results":false,"results_due":false,"sponsor_name":"Arog Pharmaceuticals, Inc.","sponsor_slug":"arog-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05341544","publication_url":"https://clinicaltrials.gov/study/NCT05341544","title":"Non-invasive Vagal Stimulation for Frequent Premature Ventricular Complexes (NoVa-PVC)","has_exemption":false,"start_date":"2022-08-22","completion_date":"2026-04-06","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05350150","publication_url":"https://clinicaltrials.gov/study/NCT05350150","title":"Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study (VNS-EPS)","has_exemption":false,"start_date":"2022-08-22","completion_date":"2026-04-06","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05864846","publication_url":"https://clinicaltrials.gov/study/NCT05864846","title":"A Phase 4, Interventional, Multicenter, Open-Label, Single-Arm Study to Assess Behavioral and Other Co-occurring Outcomes Following Treatment With EPID(I/Y)OLEX as Add-on Therapy in Participants (Aged 1 to 65 Years Old) With Seizures Associated With Tuberous Sclerosis Complex","has_exemption":false,"start_date":"2023-06-29","completion_date":"2026-04-06","has_results":false,"results_due":false,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07082816","publication_url":"https://clinicaltrials.gov/study/NCT07082816","title":"A Phase III, Prospective, Double-Masked, Randomized, Multi-Center, Active-Controlled, Parallel Group Comparison Study Assessing the Ocular Hypotensive Efficacy of Reformulated PG324 Ophthalmic Solution in Subjects With Elevated Intraocular Pressure","has_exemption":false,"start_date":"2025-09-02","completion_date":"2026-04-06","has_results":false,"results_due":false,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07280286","publication_url":"https://clinicaltrials.gov/study/NCT07280286","title":"Incidence of Intrauterine Adhesions Following Myomectomies With the Use of an Intrauterine Anti-adhesion Gel","has_exemption":false,"start_date":"2025-12-09","completion_date":"2026-04-06","has_results":false,"results_due":false,"sponsor_name":"Federico II University","sponsor_slug":"federico-ii-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04673266","publication_url":"https://clinicaltrials.gov/study/NCT04673266","title":"Romiplostim for Prevention of Severe Chemotherapy Induced Thrombocytopenia in Lymphoma Patients - Phase II Study","has_exemption":false,"start_date":"2020-12-14","completion_date":"2026-04-07","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05672251","publication_url":"https://clinicaltrials.gov/study/NCT05672251","title":"A Phase 2 Study of Loncastuximab Tesirine Plus Mosunetuzumab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma","has_exemption":false,"start_date":"2024-01-02","completion_date":"2026-04-07","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06131021","publication_url":"https://clinicaltrials.gov/study/NCT06131021","title":"Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice: A PBRN Clinical Trial","has_exemption":false,"start_date":"2024-04-25","completion_date":"2026-04-07","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06788535","publication_url":"https://clinicaltrials.gov/study/NCT06788535","title":"A Phase 3, Open-Label, Multicenter Study of I-124 Evuzamitide as an Imaging Agent for the Diagnosis of Cardiac Amyloidosis Using Positron Emission Tomography Computed Tomography (PET/CT)","has_exemption":false,"start_date":"2025-01-14","completion_date":"2026-04-08","has_results":false,"results_due":false,"sponsor_name":"Sharmila Dorbala","sponsor_slug":"sharmila-dorbala","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06696365","publication_url":"https://clinicaltrials.gov/study/NCT06696365","title":"Intermittent Theta Burst Stimulation (iTBS) as a Treatment for Alcohol Use Disorder in Inpatient Treatment","has_exemption":false,"start_date":"2025-07-18","completion_date":"2026-04-08","has_results":false,"results_due":false,"sponsor_name":"Nicholas Balderston, PhD","sponsor_slug":"nicholas-balderston-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04123795","publication_url":"https://clinicaltrials.gov/study/NCT04123795","title":"Multicenter, Open Label or Double-Blind, Placebo-Controlled Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Pediatric Study Participants With Moderate to Severe Chronic Plaque Psoriasis","has_exemption":false,"start_date":"2020-01-21","completion_date":"2026-04-09","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05612035","publication_url":"https://clinicaltrials.gov/study/NCT05612035","title":"A Phase 2a Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-5475 in Adults With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease","has_exemption":false,"start_date":"2023-03-16","completion_date":"2026-04-09","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05896163","publication_url":"https://clinicaltrials.gov/study/NCT05896163","title":"A PHASE 1B/2, OPEN-LABEL STUDY OF PF-07901801 IN COMBINATION WITH GLOFITAMAB AFTER A FIXED, SINGLE DOSE OF OBINUTUZUMAB IN PARTICIPANTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA NOT ELIGIBLE FOR STEM CELL TRANSPLANTATION","has_exemption":false,"start_date":"2023-08-30","completion_date":"2026-04-09","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06303739","publication_url":"https://clinicaltrials.gov/study/NCT06303739","title":"Induction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot Study","has_exemption":false,"start_date":"2024-04-19","completion_date":"2026-04-09","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05066997","publication_url":"https://clinicaltrials.gov/study/NCT05066997","title":"A Phase 2/3 Double-Masked, Randomized, 2 Stage, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema","has_exemption":false,"start_date":"2021-10-19","completion_date":"2026-04-10","has_results":false,"results_due":false,"sponsor_name":"Oculis","sponsor_slug":"oculis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05473858","publication_url":"https://clinicaltrials.gov/study/NCT05473858","title":"Comparative Study of the Effect of Diode Laser and Oraverse on Reversing the Effect of Articaine 4% Soft Tissue Anasthesia in Children","has_exemption":false,"start_date":"2021-12-10","completion_date":"2026-04-10","has_results":false,"results_due":false,"sponsor_name":"sara nabil","sponsor_slug":"sara-nabil","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05374187","publication_url":"https://clinicaltrials.gov/study/NCT05374187","title":"Efficacy of External Trigeminal Nerve Stimulation for Treatment of ADHD","has_exemption":false,"start_date":"2022-09-01","completion_date":"2026-04-10","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05171075","publication_url":"https://clinicaltrials.gov/study/NCT05171075","title":"A Multicenter, Randomized, Open-label, Blinded Endpoint Evaluation, Phase 3 Study Comparing the Effect of Abelacimab vs. Dalteparin on Venous Thromboembolism (VTE) Recurrence and Bleeding in Patients With GI/GU Associated VTE","has_exemption":false,"start_date":"2022-09-27","completion_date":"2026-04-10","has_results":false,"results_due":false,"sponsor_name":"Anthos Therapeutics, Inc.","sponsor_slug":"anthos-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05715268","publication_url":"https://clinicaltrials.gov/study/NCT05715268","title":"Moving MS Bladder Dysfunction Into the 21st Century: Developing Novel and Accessible Ways to Treat Dysfunction in the Home - a Three Month Single Arm Open Label Feasibility Pilot With Waitlist Control","has_exemption":false,"start_date":"2023-03-15","completion_date":"2026-04-10","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05869643","publication_url":"https://clinicaltrials.gov/study/NCT05869643","title":"A Phase 2a, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Investigate the Antiviral Effect, Safety, Tolerability, and Pharmacokinetics of STP0404 in Adults With HIV-1 Infection","has_exemption":false,"start_date":"2023-05-23","completion_date":"2026-04-10","has_results":false,"results_due":false,"sponsor_name":"ST Pharm Co., Ltd.","sponsor_slug":"st-pharm-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05669001","publication_url":"https://clinicaltrials.gov/study/NCT05669001","title":"A 12-Month, Randomized, Open-Label, Phase IIA Study Evaluating the Safety and Efficacy of Siplizumab in Combination With Belatacept and MPA Compared to Standard of Care Immunosuppression in de Novo Renal Transplant Recipients (ASCEND)","has_exemption":false,"start_date":"2023-12-28","completion_date":"2026-04-10","has_results":false,"results_due":false,"sponsor_name":"ITB-Med LLC","sponsor_slug":"itb-med-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06504446","publication_url":"https://clinicaltrials.gov/study/NCT06504446","title":"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Taplucainium Inhalation Powder (NOC-110) in Adults With Refractory or Unexplained Chronic Cough","has_exemption":false,"start_date":"2024-09-24","completion_date":"2026-04-10","has_results":false,"results_due":false,"sponsor_name":"Nocion Therapeutics","sponsor_slug":"nocion-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04889430","publication_url":"https://clinicaltrials.gov/study/NCT04889430","title":"A Multicenter, Single-arm, Open Label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily LNP023 in Adult aHUS Patients Who Are Naive to Complement Inhibitor Therapy","has_exemption":false,"start_date":"2022-01-17","completion_date":"2026-04-11","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05502315","publication_url":"https://clinicaltrials.gov/study/NCT05502315","title":"A Phase 2 Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer","has_exemption":false,"start_date":"2023-02-02","completion_date":"2026-04-12","has_results":false,"results_due":false,"sponsor_name":"Rana McKay, MD","sponsor_slug":"rana-mckay-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03508752","publication_url":"https://clinicaltrials.gov/study/NCT03508752","title":"Phase I/II Trial to Determine the Neurocognitive Decline in Patients With Multiple (>6) Brain Metastases Treated With Distributed Stereotactic Radiosurgery","has_exemption":false,"start_date":"2017-12-05","completion_date":"2026-04-13","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02615184","publication_url":"https://clinicaltrials.gov/study/NCT02615184","title":"A Phase 2, Double-Blind, 36-Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Subjects Aged 2 to 11 Years With EE","has_exemption":false,"start_date":"2023-05-23","completion_date":"2026-04-13","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06477029","publication_url":"https://clinicaltrials.gov/study/NCT06477029","title":"Modulating Ventral Striatal Activity and Connectivity With Transcranial Focused Ultrasound as a Putative Novel Intervention for Cocaine Use Disorder","has_exemption":false,"start_date":"2024-10-10","completion_date":"2026-04-13","has_results":false,"results_due":false,"sponsor_name":"Mary Phillips, MD MD (Cantab)","sponsor_slug":"mary-phillips-md-md-cantab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06593600","publication_url":"https://clinicaltrials.gov/study/NCT06593600","title":"A Phase 2 Double-Blind Placebo-Controlled Single-Dose Study of Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of REGN7544, an NPR1 Antagonist Monoclonal Antibody, in Patients With Postural Orthostatic Tachycardia Syndrome","has_exemption":false,"start_date":"2024-11-13","completion_date":"2026-04-13","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04463771","publication_url":"https://clinicaltrials.gov/study/NCT04463771","title":"An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204)","has_exemption":false,"start_date":"2021-01-26","completion_date":"2026-04-14","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04206813","publication_url":"https://clinicaltrials.gov/study/NCT04206813","title":"An Open-Label Clinical Trial Evaluating the Immunogenicity of the 9vHPV Vaccination Regimen Over 6 Months Among Women Aged 16 to 45 Years Old, An Exploratory Immunogenicity Study","has_exemption":false,"start_date":"2020-12-01","completion_date":"2026-04-15","has_results":false,"results_due":false,"sponsor_name":"Boston Medical Center","sponsor_slug":"boston-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04614194","publication_url":"https://clinicaltrials.gov/study/NCT04614194","title":"Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib and Letrozole in Hormone Receptor Positive Breast Cancer","has_exemption":false,"start_date":"2021-04-15","completion_date":"2026-04-15","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05588453","publication_url":"https://clinicaltrials.gov/study/NCT05588453","title":"A Phase I/II Study of Ex-Vivo Expanded Allogeneic Universal Donor (UD) TGFbi NK Cell Infusions in Combination With Temozolomide as a Lymphodepleting Agent in Patients With Melanoma Metastatic to the Brain","has_exemption":false,"start_date":"2023-03-01","completion_date":"2026-04-15","has_results":false,"results_due":false,"sponsor_name":"Kari Kendra","sponsor_slug":"kari-kendra","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05857137","publication_url":"https://clinicaltrials.gov/study/NCT05857137","title":"Investigational TMS Study of Cognitive Impairment in Early Psychosis","has_exemption":false,"start_date":"2023-04-04","completion_date":"2026-04-15","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06088771","publication_url":"https://clinicaltrials.gov/study/NCT06088771","title":"A Phase 1/2 Study of Combined Treatment With Dupilumab (Anti-IL-4Ra) and Cemiplimab (Anti-PD-1) in Patients With Early-stage, Resectable NSCLC","has_exemption":false,"start_date":"2024-03-08","completion_date":"2026-04-15","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06500884","publication_url":"https://clinicaltrials.gov/study/NCT06500884","title":"A Phase 2, Open-label, Randomized Study to Evaluate GPRC5D-related Oral Events","has_exemption":false,"start_date":"2024-08-26","completion_date":"2026-04-15","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07022977","publication_url":"https://clinicaltrials.gov/study/NCT07022977","title":"A Randomized, Double-blind, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MET233 in Otherwise Healthy Adult Participants With Obesity or Overweight","has_exemption":false,"start_date":"2024-11-20","completion_date":"2026-04-15","has_results":false,"results_due":false,"sponsor_name":"Metsera, a wholly owned subsidiary of Pfizer","sponsor_slug":"metsera-a-wholly-owned-subsidiary-of-pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06750653","publication_url":"https://clinicaltrials.gov/study/NCT06750653","title":"Skin Barrier Function and Inflammation in Aging: The BIA Study","has_exemption":false,"start_date":"2025-02-06","completion_date":"2026-04-15","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06761248","publication_url":"https://clinicaltrials.gov/study/NCT06761248","title":"Clinical Effectiveness of Fluorescent Starch Nanoparticles Caries Detection Rinse Versus International Caries Detection and Assessment System for Detection of Early Dental Caries in Children: a Diagnostic Accuracy Study","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-04-15","has_results":false,"results_due":false,"sponsor_name":"Cairo University","sponsor_slug":"cairo-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07525128","publication_url":"https://clinicaltrials.gov/study/NCT07525128","title":"Lateral Ridge Augmentation Using Cross-linked or Peritoneum Collagen Membrane With a Composite Allograft-xenograft Mix: a Randomized Clinical Trial","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-04-15","has_results":false,"results_due":false,"sponsor_name":"Saint-Joseph University","sponsor_slug":"saint-joseph-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06951191","publication_url":"https://clinicaltrials.gov/study/NCT06951191","title":"Applying a New Method for Pain Control in Intrauterine Device Insertion","has_exemption":false,"start_date":"2025-06-23","completion_date":"2026-04-15","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07267481","publication_url":"https://clinicaltrials.gov/study/NCT07267481","title":"Efficacy of Switching Participants Treated With Xiidra to TRYPTYR","has_exemption":false,"start_date":"2025-12-15","completion_date":"2026-04-15","has_results":false,"results_due":false,"sponsor_name":"Southern College of Optometry","sponsor_slug":"southern-college-of-optometry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07231237","publication_url":"https://clinicaltrials.gov/study/NCT07231237","title":"A Multi-site, Single-Arm Clinical Study Evaluating the Efficacy of Solventum™ Vitrebond™ Pulp Protect Liner/Base for Direct Capping of Pulpal Exposure Due to Trauma, Deep Caries, or Mechanical Etiology Under Dental Restorations","has_exemption":false,"start_date":"2026-02-17","completion_date":"2026-04-15","has_results":false,"results_due":false,"sponsor_name":"Solventum US LLC","sponsor_slug":"solventum-us-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07261137","publication_url":"https://clinicaltrials.gov/study/NCT07261137","title":"A Randomized, Controlled Clinical Study Evaluating the Efficacy of Solventum™ Vitrebond™ Pulp Protect Liner/Base Used as a Liner/Base Under Dental Restorations","has_exemption":false,"start_date":"2026-02-17","completion_date":"2026-04-15","has_results":false,"results_due":false,"sponsor_name":"Solventum US LLC","sponsor_slug":"solventum-us-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07487701","publication_url":"https://clinicaltrials.gov/study/NCT07487701","title":"Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study","has_exemption":false,"start_date":"2026-02-20","completion_date":"2026-04-15","has_results":false,"results_due":false,"sponsor_name":"Theranica","sponsor_slug":"theranica","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07470229","publication_url":"https://clinicaltrials.gov/study/NCT07470229","title":"Transcutaneous Vagus Nerve Stimulation (tVNS) and Stress Regulation During Performance Tasks","has_exemption":false,"start_date":"2026-03-15","completion_date":"2026-04-15","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05368350","publication_url":"https://clinicaltrials.gov/study/NCT05368350","title":"Treating Primary Progressive Aphasia and Apraxia of Speech With High Definition Transcranial Direct Current Stimulation (HDtDCS-PPA/PAOS)","has_exemption":false,"start_date":"2022-06-01","completion_date":"2026-04-16","has_results":false,"results_due":false,"sponsor_name":"The University of Texas at Dallas","sponsor_slug":"the-university-of-texas-at-dallas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05574400","publication_url":"https://clinicaltrials.gov/study/NCT05574400","title":"The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) Study","has_exemption":false,"start_date":"2023-02-20","completion_date":"2026-04-16","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05714969","publication_url":"https://clinicaltrials.gov/study/NCT05714969","title":"A Phase 2b, Multicenter, Randomized, Double-blind Study of Safety and Efficacy of TAK-755 (rADAMTS13) With Minimal to No Plasma Exchange (PEX) in the Treatment of Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)","has_exemption":false,"start_date":"2023-03-21","completion_date":"2026-04-16","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05481892","publication_url":"https://clinicaltrials.gov/study/NCT05481892","title":"Remote Monitoring for Equity in Advancing Control of Hypertension (REACH)","has_exemption":false,"start_date":"2023-04-20","completion_date":"2026-04-16","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06352073","publication_url":"https://clinicaltrials.gov/study/NCT06352073","title":"Dupilumab for Eosinophilic Esophagitis With Severe Strictures (DESTRICT Study)","has_exemption":false,"start_date":"2024-05-16","completion_date":"2026-04-16","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06695117","publication_url":"https://clinicaltrials.gov/study/NCT06695117","title":"A Phase 1/2, Parallel, Randomized, Modified Double-blind, Multi-arm Study to Assess the Safety and Immunogenicity of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older","has_exemption":false,"start_date":"2024-11-19","completion_date":"2026-04-16","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06744205","publication_url":"https://clinicaltrials.gov/study/NCT06744205","title":"A Phase I/II, Randomized, Modified Double-blind Study to Investigate the Safety and Immunogenicity of Different Doses of Hexavalent Influenza mRNA HA + mRNA NA Vaccine in Adult Participants 50 Years of Age and Older","has_exemption":false,"start_date":"2025-01-06","completion_date":"2026-04-16","has_results":false,"results_due":false,"sponsor_name":"Sanofi Pasteur, a Sanofi Company","sponsor_slug":"sanofi-pasteur-a-sanofi-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07079670","publication_url":"https://clinicaltrials.gov/study/NCT07079670","title":"A Phase 3 Open-Label, Single-Arm Study to Evaluate the Safety and Immunogenicity of an Omicron JN.1 Subvariant SARS-CoV-2 rS Vaccine Adjuvanted With Matrix-M","has_exemption":false,"start_date":"2025-10-09","completion_date":"2026-04-16","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04801589","publication_url":"https://clinicaltrials.gov/study/NCT04801589","title":"Maximizing Efficacy of Goal-Directed Sedation to Reduce Neurological Dysfunction in Mechanically Ventilated Infants and Children Study","has_exemption":false,"start_date":"2021-05-10","completion_date":"2026-04-17","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04848896","publication_url":"https://clinicaltrials.gov/study/NCT04848896","title":"A Prospective, Multi-center, Randomized Controlled Study to Evaluate the Safety and Effectiveness of REAL INTELLIGENCE™ CORI™ in Total Knee Arthroplasty (TKA) Procedure","has_exemption":false,"start_date":"2022-02-12","completion_date":"2026-04-17","has_results":false,"results_due":false,"sponsor_name":"Smith & Nephew, Inc.","sponsor_slug":"smith-nephew-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06161441","publication_url":"https://clinicaltrials.gov/study/NCT06161441","title":"A Phase 2 Peri-Operative Trial of Fianlimab and Cemiplimab in Combination With Chemotherapy Versus Cemiplimab in Combination With Chemotherapy in Patients With Resectable Early Stage (Stage II to IIIB [N2]) NSCLC","has_exemption":false,"start_date":"2024-07-16","completion_date":"2026-04-17","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06527404","publication_url":"https://clinicaltrials.gov/study/NCT06527404","title":"A Phase 3, 52-Week, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety, and Tolerability of Rocatinlimab in Adult Subjects With Prurigo Nodularis Who Are Inadequately Controlled on Topical Therapies or Not Eligible for Topical Therapies","has_exemption":false,"start_date":"2024-07-18","completion_date":"2026-04-17","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06630286","publication_url":"https://clinicaltrials.gov/study/NCT06630286","title":"A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate a Switch to an Oral Weekly Islatravir/Lenacapavir Regimen in People With HIV-1 Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF)","has_exemption":false,"start_date":"2024-10-09","completion_date":"2026-04-17","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06609005","publication_url":"https://clinicaltrials.gov/study/NCT06609005","title":"A Phase 1 and Phase 2, Multi-Center, Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Evidence of Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer","has_exemption":false,"start_date":"2025-01-23","completion_date":"2026-04-17","has_results":false,"results_due":false,"sponsor_name":"Shenzhen Ionova Life Sciences Co., Ltd.","sponsor_slug":"shenzhen-ionova-life-sciences-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05712356","publication_url":"https://clinicaltrials.gov/study/NCT05712356","title":"A Phase 2a, Double-blind, Placebo-controlled, Multi-center, Randomized Study Evaluating LSTA1 When Added to Standard of Care (SoC) Versus Standard of Care Alone in Subjects With Advanced Solid Tumors (BOLSTER)","has_exemption":false,"start_date":"2023-08-24","completion_date":"2026-04-18","has_results":false,"results_due":false,"sponsor_name":"Lisata Therapeutics, Inc.","sponsor_slug":"lisata-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06262594","publication_url":"https://clinicaltrials.gov/study/NCT06262594","title":"Lemborexant Treatment of Insomnia Linked to Epilepsy","has_exemption":false,"start_date":"2024-10-29","completion_date":"2026-04-18","has_results":false,"results_due":false,"sponsor_name":"University of Manitoba","sponsor_slug":"university-of-manitoba","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05718869","publication_url":"https://clinicaltrials.gov/study/NCT05718869","title":"A Phase 2 Study With a Safety Lead-In of the Anti-CD19 Antibody Tafasitamab With the BTK Inhibitor Zanubrutinib in Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) - TaZa CLL Study","has_exemption":false,"start_date":"2023-05-18","completion_date":"2026-04-19","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07473674","publication_url":"https://clinicaltrials.gov/study/NCT07473674","title":"Skin Prick Test to Evaluate Allergenic Potential of a Collagen-Based Material in Healthy Volunteers","has_exemption":false,"start_date":"2026-04-19","completion_date":"2026-04-19","has_results":false,"results_due":false,"sponsor_name":"SerenaGroup, Inc.","sponsor_slug":"serenagroup-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05849844","publication_url":"https://clinicaltrials.gov/study/NCT05849844","title":"Tympanoseal (Tympanic Membrane Device) Clinical Study","has_exemption":false,"start_date":"2024-01-05","completion_date":"2026-04-20","has_results":false,"results_due":false,"sponsor_name":"Grace Medical, Inc.","sponsor_slug":"grace-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05031455","publication_url":"https://clinicaltrials.gov/study/NCT05031455","title":"Mechanisms of Dupilumab in AERD - Effects on Aspirin Hypersensitivity Response, With a Focus on Innate Type 2 Inflammatory Responses","has_exemption":false,"start_date":"2024-03-25","completion_date":"2026-04-20","has_results":false,"results_due":false,"sponsor_name":"Scripps Clinic","sponsor_slug":"scripps-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06926933","publication_url":"https://clinicaltrials.gov/study/NCT06926933","title":"An Open Label, Single-group, Multicenter Study on the Efficacy and Safety of Leuprolide Acetate 45 mg for Injectable Suspension-controlled Release in Subjects With Central (Gonadotropin-dependent) Precocious Puberty","has_exemption":false,"start_date":"2024-12-12","completion_date":"2026-04-20","has_results":false,"results_due":false,"sponsor_name":"HanAll BioPharma Co., Ltd.","sponsor_slug":"hanall-biopharma-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07243756","publication_url":"https://clinicaltrials.gov/study/NCT07243756","title":"A Pilot Proof of Concept Study, Single-center, Open-label Study to Assess the Safety and Efficacy of an Ingestible Pill for Gut Microbiome Sampling in Healthy Humans","has_exemption":false,"start_date":"2026-01-21","completion_date":"2026-04-20","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07398846","publication_url":"https://clinicaltrials.gov/study/NCT07398846","title":"A 12-Week Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste, Cetylpyridinium Chloride Mouthwash, and Battery Toothbrush Regimen in Reducing Established Dental Plaque and Gingivitis.","has_exemption":false,"start_date":"2026-01-26","completion_date":"2026-04-20","has_results":false,"results_due":false,"sponsor_name":"Colgate Palmolive","sponsor_slug":"colgate-palmolive","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07356323","publication_url":"https://clinicaltrials.gov/study/NCT07356323","title":"A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery","has_exemption":false,"start_date":"2026-02-19","completion_date":"2026-04-20","has_results":false,"results_due":false,"sponsor_name":"Solventum US LLC","sponsor_slug":"solventum-us-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05135559","publication_url":"https://clinicaltrials.gov/study/NCT05135559","title":"Open-label Study Investigating Efficacy, Safety and Pharmacokinetics of Concizumab Prophylaxis in Children Below 12 Years With Haemophilia A or B With or Without Inhibitors","has_exemption":false,"start_date":"2022-03-24","completion_date":"2026-04-21","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05268003","publication_url":"https://clinicaltrials.gov/study/NCT05268003","title":"A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia","has_exemption":false,"start_date":"2022-06-07","completion_date":"2026-04-21","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04700527","publication_url":"https://clinicaltrials.gov/study/NCT04700527","title":"LCCC2032: The Effects of Short Chain Fatty Acid Supplementation on the Quality of Life and Treatment-related Toxicities in Subjects Receiving Abdominopelvic Radiotherapy: A Randomized Controlled Study","has_exemption":false,"start_date":"2023-12-15","completion_date":"2026-04-21","has_results":false,"results_due":false,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04331119","publication_url":"https://clinicaltrials.gov/study/NCT04331119","title":"Phase II Trial With Safety Lead in of Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas","has_exemption":false,"start_date":"2020-07-23","completion_date":"2026-04-22","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04696809","publication_url":"https://clinicaltrials.gov/study/NCT04696809","title":"A Phase 1/2 Study of JNJ-64007957, a Humanized BCMA * CD3 Bispecific Antibody in Japanese Patients With Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2021-02-22","completion_date":"2026-04-22","has_results":false,"results_due":false,"sponsor_name":"Janssen Pharmaceutical K.K.","sponsor_slug":"janssen-pharmaceutical-kk","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05144841","publication_url":"https://clinicaltrials.gov/study/NCT05144841","title":"A Phase 2 Open-label Clinical Study to Evaluate the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (waveLINE-004)","has_exemption":false,"start_date":"2022-01-08","completion_date":"2026-04-22","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05467670","publication_url":"https://clinicaltrials.gov/study/NCT05467670","title":"Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Patients With Recurrent Platinum-resistant Ovarian Cancer: Phase II Study","has_exemption":false,"start_date":"2023-03-30","completion_date":"2026-04-22","has_results":false,"results_due":false,"sponsor_name":"Alexander B Olawaiye, MD","sponsor_slug":"alexander-b-olawaiye-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06388187","publication_url":"https://clinicaltrials.gov/study/NCT06388187","title":"Efficacy and Safety of Cagrilintide s.c. in Combination With Semaglutide s.c.(CagriSema s.c. 1.0 mg/1.0 mg and 1.7 mg/1.7 mg) Once-weekly in Participants With Overweight or Obesity","has_exemption":false,"start_date":"2024-06-24","completion_date":"2026-04-22","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06600789","publication_url":"https://clinicaltrials.gov/study/NCT06600789","title":"A Modular, Multi-Part, Multi-Arm, Phase 1/2 Study to Evaluate the Safety and Tolerability of CT7439 Alone and in Combination With Anticancer Treatments in Participants With Solid Malignancies","has_exemption":false,"start_date":"2024-08-16","completion_date":"2026-04-22","has_results":false,"results_due":false,"sponsor_name":"Carrick Therapeutics Limited","sponsor_slug":"carrick-therapeutics-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06717815","publication_url":"https://clinicaltrials.gov/study/NCT06717815","title":"A Multi-center, Multi-dose Phase Ib/IIa Clinical Study Evaluating the Safety, Tolerability, Preliminary Efficacy, Pharmacokinetics, and Impact on Biomarkers of IPG11406 in Patients With Lupus Nephritis","has_exemption":false,"start_date":"2025-02-25","completion_date":"2026-04-22","has_results":false,"results_due":false,"sponsor_name":"Nanjing Immunophage Biotech Co., Ltd","sponsor_slug":"nanjing-immunophage-biotech-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06973577","publication_url":"https://clinicaltrials.gov/study/NCT06973577","title":"A Phase 3b, Randomized, Double-blind, 8-week, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Centanafadine Once Daily Extended-release Capsules for the Treatment of Adults With Attention-deficit/Hyperactivity Disorder and Comorbid Anxiety","has_exemption":false,"start_date":"2025-03-26","completion_date":"2026-04-22","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06973291","publication_url":"https://clinicaltrials.gov/study/NCT06973291","title":"A Phase 3, Randomized, Multicenter, Double-Blind Trial to Evaluate the Efficacy, Safety, and Tolerability of Zasocitinib (TAK-279) Compared to Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis","has_exemption":false,"start_date":"2025-07-09","completion_date":"2026-04-22","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04979052","publication_url":"https://clinicaltrials.gov/study/NCT04979052","title":"Safety and Efficacy of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Candidemia","has_exemption":false,"start_date":"2022-03-31","completion_date":"2026-04-23","has_results":false,"results_due":false,"sponsor_name":"Radboud University Medical Center","sponsor_slug":"radboud-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06208150","publication_url":"https://clinicaltrials.gov/study/NCT06208150","title":"A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in Combination With Teclistamab (Tal-Tec), and Investigator's Choice of Either Elotuzumab, Pomalidomide, and Dexamethasone (EPd) or Pomalidomide, Bortezomib, and Dexamethasone (PVd) in Participants With Relapsed or Refractory Myeloma Who Have Received 1 to 4 Prior Lines of Therapy Including an Anti-CD38 Antibody and Lenalidomide","has_exemption":false,"start_date":"2024-01-22","completion_date":"2026-04-23","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06576908","publication_url":"https://clinicaltrials.gov/study/NCT06576908","title":"Evaluation of Image Quality From an On-Couch, Cone Beam Computed Tomography (CBCT) Radiation Treatment System for Image Guidance and Treatment Adaptation","has_exemption":false,"start_date":"2024-10-17","completion_date":"2026-04-23","has_results":false,"results_due":false,"sponsor_name":"Varian, a Siemens Healthineers Company","sponsor_slug":"varian-a-siemens-healthineers-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06777433","publication_url":"https://clinicaltrials.gov/study/NCT06777433","title":"An Open-Label, Single Dose, Single Arm, Multicenter Phase 2b Study to Establish the Imaging Performance of RAD101 Positron Emission Tomography (PET) in Participants With Suspected Recurrent Brain Metastases From Solid Tumors","has_exemption":false,"start_date":"2024-12-13","completion_date":"2026-04-23","has_results":false,"results_due":false,"sponsor_name":"Radiopharm Theranostics, Ltd","sponsor_slug":"radiopharm-theranostics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07447882","publication_url":"https://clinicaltrials.gov/study/NCT07447882","title":"Unilateral M1 Anodal tDCS to Enhance Learning in a Gross Movement Videogame Task","has_exemption":false,"start_date":"2025-04-23","completion_date":"2026-04-23","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07081958","publication_url":"https://clinicaltrials.gov/study/NCT07081958","title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center, Phase II Study to Evaluate the Efficacy, Safety, and Tolerability of Once-Daily RO7795081 Administered for 38 Weeks to Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity","has_exemption":false,"start_date":"2025-07-29","completion_date":"2026-04-23","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01742299","publication_url":"https://clinicaltrials.gov/study/NCT01742299","title":"An Open Label, Multi-center Imatinib Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Imatinib Study and Are Judged by the Investigator to Benefit From Continued Imatinib Treatment","has_exemption":false,"start_date":"2013-03-26","completion_date":"2026-04-24","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05156268","publication_url":"https://clinicaltrials.gov/study/NCT05156268","title":"A Phase II Trial of Pembrolizumab Plus Olaparib for the Treatment of Patients With Persistent/Recurrent Endometrial Cancers","has_exemption":false,"start_date":"2022-01-27","completion_date":"2026-04-24","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06267521","publication_url":"https://clinicaltrials.gov/study/NCT06267521","title":"Hybrid Interventions to Optimize Neural Plasticity and Enhance Well-being: Mental Exercise, and Transcranial Electrical Stimulation With Temporal Interference: The STRENGTHEN Study - Phase 1 and 2","has_exemption":false,"start_date":"2024-03-06","completion_date":"2026-04-24","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06284434","publication_url":"https://clinicaltrials.gov/study/NCT06284434","title":"Liposomal Bupivacaine Use in Alveolar Bone Graft Patients","has_exemption":false,"start_date":"2024-04-24","completion_date":"2026-04-24","has_results":false,"results_due":false,"sponsor_name":"Kerry O'Rourke","sponsor_slug":"kerry-orourke","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05354557","publication_url":"https://clinicaltrials.gov/study/NCT05354557","title":"Phase II Multicenter Trial of Iberdomide as Maintenance Therapy for Multiple Myeloma Patients With Sub-Optimal Response After Autologous Hematopoietic Cell Transplantation or After Salvage Autologous Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2022-04-26","completion_date":"2026-04-26","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05488873","publication_url":"https://clinicaltrials.gov/study/NCT05488873","title":"A Randomized, Double-Blind, Placebo-Controlled, Study of Topical Pirenzepine or Placebo for the Prevention of Dose Limiting Chemotherapy Induced Peripheral Neuropathy in Oncology Patients Administered Carboplatin and Paclitaxel","has_exemption":false,"start_date":"2022-11-22","completion_date":"2026-04-26","has_results":false,"results_due":false,"sponsor_name":"WinSanTor, Inc","sponsor_slug":"winsantor-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04762069","publication_url":"https://clinicaltrials.gov/study/NCT04762069","title":"A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy","has_exemption":false,"start_date":"2021-05-18","completion_date":"2026-04-27","has_results":false,"results_due":false,"sponsor_name":"CNS Pharmaceuticals, Inc.","sponsor_slug":"cns-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05020236","publication_url":"https://clinicaltrials.gov/study/NCT05020236","title":"AN OPEN-LABEL, 3-ARM, MULTICENTER, RANDOMIZED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135) MONOTHERAPY AND ELRANATAMAB + DARATUMUMAB VERSUS DARATUMUMAB + POMALIDOMIDE + DEXAMETHASONE IN PARTICIPANTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST 1 PRIOR LINE OF THERAPY INCLUDING LENALIDOMIDE AND A PROTEASOME INHIBITOR","has_exemption":false,"start_date":"2021-10-04","completion_date":"2026-04-27","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05133440","publication_url":"https://clinicaltrials.gov/study/NCT05133440","title":"SAXON-PC: A Phase II Randomized Trial of Stereotactic Body Radiation Therapy (SBRT) And Radium (Ra-223) Dichloride for Oligorecurrent, Non-castrate Resistant Prostate Cancer","has_exemption":false,"start_date":"2021-11-12","completion_date":"2026-04-27","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04745910","publication_url":"https://clinicaltrials.gov/study/NCT04745910","title":"Effect of Pegloticase on Reduction of Uric Acid in Patients With Tumor Lysis Syndrome: A Pilot Pragmatic Clinical Trial","has_exemption":false,"start_date":"2022-04-05","completion_date":"2026-04-27","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07135986","publication_url":"https://clinicaltrials.gov/study/NCT07135986","title":"A Phase 3, Modified Double-blind, Multi-center Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents (2 to 17 Years of Age) in China","has_exemption":false,"start_date":"2025-09-26","completion_date":"2026-04-27","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03612648","publication_url":"https://clinicaltrials.gov/study/NCT03612648","title":"Evaluation of Three Fraction Accelerated Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-risk Stage 0 and I Breast Carcinoma","has_exemption":false,"start_date":"2018-08-30","completion_date":"2026-04-28","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03312400","publication_url":"https://clinicaltrials.gov/study/NCT03312400","title":"Low Dose Danazol for the Treatment of Telomere Related Diseases","has_exemption":false,"start_date":"2018-02-08","completion_date":"2026-04-29","has_results":false,"results_due":false,"sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","sponsor_slug":"national-heart-lung-and-blood-institute-nhlbi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03682068","publication_url":"https://clinicaltrials.gov/study/NCT03682068","title":"A Phase III, Randomized, Open-Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab in Combination With Standard of Care Chemotherapy and Durvalumab in Combination With Tremelimumab and Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone in Patients With Unresectable Locally Advanced or Metastatic Urothelial Cancer.","has_exemption":false,"start_date":"2018-09-27","completion_date":"2026-04-29","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04440280","publication_url":"https://clinicaltrials.gov/study/NCT04440280","title":"Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy","has_exemption":false,"start_date":"2020-09-16","completion_date":"2026-04-29","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Eye and Ear Infirmary","sponsor_slug":"massachusetts-eye-and-ear-infirmary","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06223958","publication_url":"https://clinicaltrials.gov/study/NCT06223958","title":"A Phase 3, Multicenter, Double-Masked, Randomized, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)","has_exemption":false,"start_date":"2024-01-29","completion_date":"2026-04-29","has_results":false,"results_due":false,"sponsor_name":"Ocular Therapeutix, Inc.","sponsor_slug":"ocular-therapeutix-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01451502","publication_url":"https://clinicaltrials.gov/study/NCT01451502","title":"Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units","has_exemption":false,"start_date":"2011-10-20","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01582204","publication_url":"https://clinicaltrials.gov/study/NCT01582204","title":"Pilot Trial To Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma","has_exemption":false,"start_date":"2012-04-30","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04296604","publication_url":"https://clinicaltrials.gov/study/NCT04296604","title":"Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations","has_exemption":false,"start_date":"2014-09-30","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02202772","publication_url":"https://clinicaltrials.gov/study/NCT02202772","title":"A Phase I/II Trial for the Use of Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment of BCG-Refractory Non-muscle Invasive Urothelial Carcinoma of the Bladder Cancer","has_exemption":false,"start_date":"2014-12-01","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Guarionex J. Decastro","sponsor_slug":"guarionex-j-decastro","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02421380","publication_url":"https://clinicaltrials.gov/study/NCT02421380","title":"Characterization of Hyperpolarized Pyruvate MRI Reproducibility","has_exemption":false,"start_date":"2015-04-30","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02414269","publication_url":"https://clinicaltrials.gov/study/NCT02414269","title":"A Phase I/II Clinical Trial of Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin","has_exemption":false,"start_date":"2015-05-31","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02750319","publication_url":"https://clinicaltrials.gov/study/NCT02750319","title":"A Randomized, Double-Blind, Controlled Trial of Combined Amiodarone and N-Acetylcysteine Versus Amiodarone Plus Placebo for the Prevention of Atrial Fibrillation in High Risk Patients Undergoing Thoracic Surgery","has_exemption":false,"start_date":"2016-04-30","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02769520","publication_url":"https://clinicaltrials.gov/study/NCT02769520","title":"An Open-Label, Phase 2 Efficacy Study With Window of Opportunity Immune Assessment of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)","has_exemption":false,"start_date":"2016-07-06","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Assuntina G. Sacco, MD","sponsor_slug":"assuntina-g-sacco-md","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02848131","publication_url":"https://clinicaltrials.gov/study/NCT02848131","title":"Senescence, Frailty, and Mesenchymal Stem Cell Functionality in Chronic Kidney Disease: Effect of Senolytic Agents","has_exemption":false,"start_date":"2016-07-31","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02544308","publication_url":"https://clinicaltrials.gov/study/NCT02544308","title":"Phase III Randomised Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma","has_exemption":false,"start_date":"2017-03-10","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"University College, London","sponsor_slug":"university-college-london","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03089554","publication_url":"https://clinicaltrials.gov/study/NCT03089554","title":"Integration of Precision Medicine Into Cancer Therapeutics, Part 2: A Therapeutic Phase 2 Sub-study Evaluating Genomic Testing in Human Cancer and Outcomes of Targeted Therapies Recommended by an Institutional Multidisciplinary Molecular Tumor Board in Patients With Poor Prognosis Cancer","has_exemption":false,"start_date":"2017-04-11","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Rachel Miller","sponsor_slug":"rachel-miller","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03121014","publication_url":"https://clinicaltrials.gov/study/NCT03121014","title":"A Phase II Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes","has_exemption":false,"start_date":"2017-04-24","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03319901","publication_url":"https://clinicaltrials.gov/study/NCT03319901","title":"A Phase Ib Study of the Combination of Venetoclax With Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia","has_exemption":false,"start_date":"2017-10-30","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03274492","publication_url":"https://clinicaltrials.gov/study/NCT03274492","title":"A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Polatuzumab Vedotin in Combination With Rituximab and CHP (R-CHP) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients With Diffuse Large B-Cell Lymphoma","has_exemption":false,"start_date":"2017-11-16","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03285412","publication_url":"https://clinicaltrials.gov/study/NCT03285412","title":"Phase II Study of CDK 4/6 Inhibitor, LEE011 (Ribociclib), in Combination With Adjuvant Endocrine Therapy at Varying Duration for ER-positive Breast Cancer (LEADER).","has_exemption":false,"start_date":"2017-12-12","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03271372","publication_url":"https://clinicaltrials.gov/study/NCT03271372","title":"A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial of Adjuvant Avelumab (Anti-PDL-1 Antibody) in Merkel Cell Carcinoma Patients With Lymph Node Metastases","has_exemption":false,"start_date":"2017-12-19","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03646214","publication_url":"https://clinicaltrials.gov/study/NCT03646214","title":"Oral Appliance Therapy for Improving Sleep Quality During Pregnancy: A Controlled Clinical Trial","has_exemption":false,"start_date":"2018-02-01","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Texas A&M University","sponsor_slug":"texas-am-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03430037","publication_url":"https://clinicaltrials.gov/study/NCT03430037","title":"AFFIRM: A Phase 2 Randomized, Placebo-Controlled Study of Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women","has_exemption":false,"start_date":"2018-02-06","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03363373","publication_url":"https://clinicaltrials.gov/study/NCT03363373","title":"A Pivotal Phase 2 Trial of Antibody Naxitamab (hu3F8) and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow","has_exemption":false,"start_date":"2018-04-03","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Y-mAbs Therapeutics","sponsor_slug":"y-mabs-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03583957","publication_url":"https://clinicaltrials.gov/study/NCT03583957","title":"A Wireless EEG Patch for Continuous Electrographic Monitoring","has_exemption":false,"start_date":"2018-05-08","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Epitel, Inc.","sponsor_slug":"epitel-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03504163","publication_url":"https://clinicaltrials.gov/study/NCT03504163","title":"Phase II Study of Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle- Invasive Bladder Cancer (NMIBC) and High- Grade Non-Muscle- Invasive Upper Tract Urothelial Cell Carcinoma (NMI-UTUCC)","has_exemption":false,"start_date":"2018-06-27","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03614234","publication_url":"https://clinicaltrials.gov/study/NCT03614234","title":"Open Label Extension Study to Evaluate the Long-term Safety and Efficacy of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Administered by Intravenous Infusion Every 4 Weeks in Adult Patients With Fabry Disease","has_exemption":false,"start_date":"2018-11-13","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Chiesi Farmaceutici S.p.A.","sponsor_slug":"chiesi-farmaceutici-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03675724","publication_url":"https://clinicaltrials.gov/study/NCT03675724","title":"AFFIRM-LITE: A Phase 2 Randomized, Placebo-Controlled Study of Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Adults","has_exemption":false,"start_date":"2018-11-15","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03945318","publication_url":"https://clinicaltrials.gov/study/NCT03945318","title":"A Phase 1/2, Multicenter Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy","has_exemption":false,"start_date":"2019-04-08","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04042922","publication_url":"https://clinicaltrials.gov/study/NCT04042922","title":"Acute Treatment of Alzheimer's Disease With Gamma Frequency Stimulation","has_exemption":false,"start_date":"2019-04-19","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Institute of Technology","sponsor_slug":"massachusetts-institute-of-technology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03905707","publication_url":"https://clinicaltrials.gov/study/NCT03905707","title":"A Double-Blind Phase 3 Extension Trial Assessing the Long Term Safety and Efficacy of Glepaglutide in Patients With Short Bowel Syndrome (SBS)","has_exemption":false,"start_date":"2019-05-07","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Zealand Pharma","sponsor_slug":"zealand-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03650764","publication_url":"https://clinicaltrials.gov/study/NCT03650764","title":"A Prospective Phase I and II Trial of Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2019-05-29","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03942653","publication_url":"https://clinicaltrials.gov/study/NCT03942653","title":"Phase II Trial of Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma: Big Ten Cancer Research Consortium BTCRC-HN17-111","has_exemption":false,"start_date":"2019-05-30","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Manish Patel","sponsor_slug":"manish-patel","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03551392","publication_url":"https://clinicaltrials.gov/study/NCT03551392","title":"Pilot Intervention With Near Infrared Stimulation: Revitalizing Cognition in Older Adults and Those With Parkinson Disease","has_exemption":false,"start_date":"2019-06-26","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04034030","publication_url":"https://clinicaltrials.gov/study/NCT04034030","title":"Repeated Oscillatory Transcranial Magnetic Stimulation Therapy of the Epileptogenic Cortical Area in Children With Focal Continuous-Spike and Wave During Sleep","has_exemption":false,"start_date":"2019-08-01","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Children's Mercy Hospital Kansas City","sponsor_slug":"childrens-mercy-hospital-kansas-city","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03821246","publication_url":"https://clinicaltrials.gov/study/NCT03821246","title":"An Open-Label Multi-Center Phase II Study of Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy","has_exemption":false,"start_date":"2019-10-30","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"David Oh","sponsor_slug":"david-oh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04136171","publication_url":"https://clinicaltrials.gov/study/NCT04136171","title":"A Phase 3 Global, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ION-682884 in Patients With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)","has_exemption":false,"start_date":"2020-03-13","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Ionis Pharmaceuticals, Inc.","sponsor_slug":"ionis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04379050","publication_url":"https://clinicaltrials.gov/study/NCT04379050","title":"An Open-label Extension of Study M15-741 to Evaluate the Safety and Tolerability of 24-hour Daily Exposure of Continuous Subcutaneous Infusion of ABBV-951 in Subjects With Parkinson's Disease","has_exemption":false,"start_date":"2020-06-08","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04246281","publication_url":"https://clinicaltrials.gov/study/NCT04246281","title":"A Randomized, Controlled, Multicenter Trial of Percutaneous Peripheral Nerve Stimulation (PNS) for the Treatment of Back Pain","has_exemption":false,"start_date":"2020-06-17","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"SPR Therapeutics, Inc.","sponsor_slug":"spr-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04430699","publication_url":"https://clinicaltrials.gov/study/NCT04430699","title":"A Phase 2 Study of Combined Chemo-immunotherapy With Cisplatin-pembrolizumab and Radiation for Unresectable Vulvar Squamous Cell Carcinoma","has_exemption":false,"start_date":"2020-07-29","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04332367","publication_url":"https://clinicaltrials.gov/study/NCT04332367","title":"Phase II, Single-Arm Study Of Carboplatin, Weekly Taxane, And Ramucirumab In Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) After Progressive Disease On Maintenance Pemetrexed And/Or Pembrolizumab","has_exemption":false,"start_date":"2020-08-01","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04542161","publication_url":"https://clinicaltrials.gov/study/NCT04542161","title":"Mechanistic Assessment of N-Acetylcysteine as an Antioxidant Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Through Dose Response and Treatment Target Engagement","has_exemption":false,"start_date":"2020-09-01","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03754725","publication_url":"https://clinicaltrials.gov/study/NCT03754725","title":"A Phase 1/2a Exploratory Clinical Trial to Evaluate the Safety of Oral Deferiprone (14 Days) Including Its Effect on Decreasing the Content of Iron in Subjects With Aneurysmal Subarachnoid Hemorrhage (aSAH) sIRB","has_exemption":false,"start_date":"2020-10-01","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03527108","publication_url":"https://clinicaltrials.gov/study/NCT03527108","title":"A Phase 2 Study of Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic Non-Small Cell Lung Carcinoma","has_exemption":false,"start_date":"2020-10-08","completion_date":"2026-04-30","has_results":false,"results_due":false,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"ongoing","is_pact":false,"days_late":null}]}